INTRA-CELLULAR THERAPIES INC

CUSIP: 46116X101 Class: Common Stock

Raleigh Capital Management Inc.'s Holding History (CIK: 0001911726)

Note: Option positions (PUT/CALL) are excluded.

Q4 2023
Shares 107 Value ($000) $8 Avg Close — Range —
Q3 2023
Shares 103 Value ($000) $5 Avg Close — Range —
Q2 2023
Shares 61 Value ($000) $4 Avg Close — Range —
Q1 2023
Shares 41 Value ($000) $2 Avg Close — Range —
Q4 2022
Shares 32 Value ($000) $2 Avg Close — Range —
Q3 2022
Shares 16 Value ($000) $1 Avg Close — Range —